With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with a transaction set to propel the company into the CDMO market.
ST. PETERSBURG, Fla., January 15, 2025--(BUSINESS WIRE)--Jabil Inc. (NYSE: JBL) today announced it will host its Annual Meeting of Stockholders in a virtual only format on January 23, 2025 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback